Thyrocare Technologies Ltd - Board to consider FY21 results & Final Dividend on May 08, 2021

Thyrocare Technologies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 08, 2021, inter alia, to consider and approve Audited Stand-alone and Consolidated Financial Results of the Company for the quarter / financial year ended March 31, 2021, to consider recommending final dividend, if any, for the financial year 2020-21, and to consider granting of Employee Stock Options for the financial year ended March 31, 2021.